Ann: Appendix 4C - quarterly, page-12

I don't see why continuous improvement in their product is necessarily a bad thing, It doesn't preclude Alexium from selling the existing product.

From the current 4C. Fracu is still a while away but the other FR initiative may be closer. Wonder when they'll be able to provide more information on that as they say their MOU preclude the Company from providing significant additional detail at this time.

There was hope that Alexium NF would begin sales in Europe sooner as it was more progressed in terms of regulation but seems all quiet on that front.

I guess we await the AGM to see whats new.